{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:06:50Z","timestamp":1753272410047,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570658"],"award-info":[{"award-number":["81570658"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Glomerular disease patients have a high risk of infection, which contributes to the progression of disease per se and mortality, especially in those with long-term use of glucocorticoids and (or) immunosuppressive agents. Cases of sporadic nocardiosis have been reported in glomerular disease patients, and this observation was conducted to comprehensively understand the manifestations of and treatments for nocardiosis, which is commonly misdiagnosed as pneumonia or tuberculosis or even as lung cancer or metastatic tumors in glomerular disease patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We reviewed the demographic characteristics, laboratory abnormalities, radiological features, and treatments of 7 patients with nocardiosis and glomerular disease receiving steroids and immunosuppression therapy at the nephrology department of the Second Xiangya Hospital between 2012 and 2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>It was found that all 7 patients had been receiving methylprednisolone for renal disease at a median dose of 20\u2009mg per day and a median duration of 4\u2009months before developing nocardiosis. There were 4 males and 3 females, and the median age was 52.14\u2009years. All 7 patients had hypoalbuminemia at the time of admission. In addition, various cystic abscesses in the subcutaneous tissue, with or without lung and brain involvement, were observed in these patients. Encouragingly, body temperatures returned to normal, and subcutaneous abscesses diminished or disappeared with compound sulfamethoxazole treatment alone or in combination with linezolid, imipenem and mezlocillin\/sulbactam.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>It was shown that multisite abscesses, including subcutaneous, pulmonary and cerebral abscesses, were the common manifestations of nocardiosis in glomerular disease patients. Sulfonamide was the first-line antibiotic therapy for nocardiosis, and combinations of other antibiotics were also needed in some serious cases.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-020-02179-9","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T12:03:40Z","timestamp":1606392220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nocardiosis in glomerular disease patients with immunosuppressive therapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Yuzhang","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5488-5583","authenticated-orcid":false,"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"issue":"2","key":"2179_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.kint.2018.10.018","volume":"95","author":"J Floege","year":"2019","unstructured":"Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, et al. Management and treatment of glomerular diseases (part 1): conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2019;95(2):268\u201380.","journal-title":"Kidney Int"},{"issue":"4","key":"2179_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2215\/CJN.10871016","volume":"12","author":"MM O'Shaughnessy","year":"2017","unstructured":"O'Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, Jennette JC. Temporal and demographic trends in glomerular disease epidemiology in the southeastern United States, 1986-2015. Clin J Am Soc Nephrol. 2017;12(4):614\u201323.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10041","key":"2179_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(16)30448-2","volume":"388","author":"BM Robinson","year":"2016","unstructured":"Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388(10041):294\u2013306.","journal-title":"Lancet"},{"issue":"13","key":"2179_CR4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. Jama. 2019;322(13):1294\u2013304.","journal-title":"Jama"},{"issue":"3","key":"2179_CR5","first-page":"Cd003965","volume":"3","author":"P Natale","year":"2020","unstructured":"Natale P, Palmer SC, Ruospo M, Saglimbene VM, Craig JC, Vecchio M, Samuels JA, Molony DA, Schena FP, Strippoli GF. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database Syst Rev. 2020;3(3):Cd003965.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2179_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.autrev.2012.11.012","volume":"12","author":"A Pani","year":"2013","unstructured":"Pani A. Standard immunosuppressive therapy of immune-mediated glomerular diseases. Autoimmun Rev. 2013;12(8):848\u201353.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"2179_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nri3523","volume":"13","author":"K Christian","year":"2013","unstructured":"Christian K, Ulf P, Hans-Joachim A, Rees AJ. The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol. 2013;13(10):738\u201353.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2179_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2215\/CJN.12991117","volume":"13","author":"C Ponticelli","year":"2018","unstructured":"Ponticelli C, Locatelli F. Glucocorticoids in the treatment of glomerular diseases: pitfalls and pearls. Clin J Am Soc Nephrol. 2018;13(5):815\u201322.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2179_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002024","volume":"13","author":"L Fardet","year":"2016","unstructured":"Fardet L, Petersen I, Nazareth I. Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. PLoS Med. 2016;13(5):e1002024.","journal-title":"PLoS Med"},{"issue":"8","key":"2179_CR10","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2215\/CJN.01920218","volume":"13","author":"JA Jefferson","year":"2018","unstructured":"Jefferson JA. Complications of immunosuppression in glomerular disease. Clin J Am Soc Nephrol. 2018;13(8):1264\u201375.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2179_CR11","first-page":"480","volume":"31","author":"E Cholongitas","year":"2018","unstructured":"Cholongitas E, Haidich AB, Apostolidou-Kiouti F, Chalevas P, Papatheodoridis GV. Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review. Ann Gastroenterol. 2018;31(4):480\u201390.","journal-title":"Ann Gastroenterol"},{"issue":"7","key":"2179_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/nep.13071","volume":"23","author":"CC Lim","year":"2018","unstructured":"Lim CC, Tung YT, Tan BH, Lee PH, Mok I, Oon L, Chan KP, Choo JC. Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy. Nephrology (Carlton). 2018;23(7):676\u201381.","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"2179_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.kint.2016.07.013","volume":"90","author":"HIC Hassan","year":"2016","unstructured":"Hassan HIC, Tang M, Djurdjev O, Langsford D, Sood MM, Levin A. Infection in advanced chronic kidney disease leadsto increased risk of cardiovascular events, end-stage kidney disease and mortality. Kidney Int. 2016;90(4):897\u2013904.","journal-title":"Kidney Int"},{"issue":"1","key":"2179_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013892","volume":"98","author":"X Yin","year":"2019","unstructured":"Yin X, Ge H, Miao R. A case report of ocular tuberculosis in a patient with membranous nephropathy. Medicine (Baltimore). 2019;98(1):e13892.","journal-title":"Medicine (Baltimore)"},{"issue":"9461","key":"2179_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(05)17989-6","volume":"365","author":"F Buttgereit","year":"2005","unstructured":"Buttgereit F, Burmester GR, Lipworth BJ. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet. 2005;365(9461):801\u20133.","journal-title":"Lancet"},{"issue":"23","key":"2179_CR16","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","volume":"373","author":"R Thomas","year":"2015","unstructured":"Thomas R, Frank E, Christina F, Claudia S, Martin Z, Britta O, Ulf P, Harm P, Urs B, Mertens PR. Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med. 2015;373(23):2225\u201336.","journal-title":"N Engl J Med"},{"issue":"1","key":"2179_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1053\/j.ackd.2018.10.001","volume":"26","author":"M Narayanan","year":"2019","unstructured":"Narayanan M. The many faces of infection in CKD: evolving paradigms, insights, and novel therapies. Adv Chronic Kidney Dis. 2019;26(1):5\u20137.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"2179_CR18","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1177\/0300060517715339","volume":"45","author":"J Li","year":"2017","unstructured":"Li J, Zhang Q, Su B. Clinical characteristics and risk factors of severe infections in hospitalized adult patients with primary nephrotic syndrome. J Int Med Res. 2017;45(6):2139\u201345.","journal-title":"J Int Med Res"},{"issue":"7","key":"2179_CR19","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1177\/0961203318768881","volume":"27","author":"P Liu","year":"2018","unstructured":"Liu P, Tan HZ, Li H, Lim CC, Choo JCJ. Infections in hospitalized lupus nephritis patients: characteristics, risk factors, and outcomes. Lupus. 2018;27(7):1150\u20138.","journal-title":"Lupus"},{"issue":"1","key":"2179_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/BOR.0000000000000348","volume":"29","author":"K Thomas","year":"2017","unstructured":"Thomas K, Vassilopoulos D. Infections and vasculitis. Curr Opin Rheumatol. 2017;29(1):17\u201323.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"2179_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1128\/CMR.7.2.213","volume":"7","author":"BL Beaman","year":"1994","unstructured":"Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994;7(2):213.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"2179_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1128\/CMR.7.3.357","volume":"7","author":"MM Mcneil","year":"1994","unstructured":"Mcneil MM, Brown JM. The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev. 1994;7(3):357.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"2179_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s15010-009-9193-9","volume":"38","author":"J Ambrosioni","year":"2010","unstructured":"Ambrosioni J, Lew D, Garbino J. Nocardiosis: updated clinical review and experience at a tertiary center. Infection. 2010;38(2):89\u201397.","journal-title":"Infection"},{"issue":"40","key":"2179_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012436","volume":"97","author":"J Steinbrink","year":"2018","unstructured":"Steinbrink J, Leavens J, Kauffman CA, Miceli MH. Manifestations and outcomes of nocardia infections: comparison of immunocompromised and nonimmunocompromised adult patients. Medicine (Baltimore). 2018;97(40):e12436.","journal-title":"Medicine (Baltimore)"},{"key":"2179_CR25","first-page":"14","volume":"18","author":"G Castellana","year":"2016","unstructured":"Castellana G, Grimaldi A, Castellana M, Farina C, Castellana G. Pulmonary nocardiosis in chronic obstructive pulmonary disease: a new clinical challenge. Respir Med Case Rep. 2016;18:14\u201321.","journal-title":"Respir Med Case Rep"},{"issue":"8","key":"2179_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jfma.2013.07.017","volume":"114","author":"HK Wang","year":"2015","unstructured":"Wang HK, Sheng WH, Hung CC, Chen YC, Lee MH, Lin WS, Hsueh PR, Chang SC. Clinical characteristics, microbiology, and outcomes for patients with lung and disseminated nocardiosis in a tertiary hospital. J Formos Med Assoc. 2015;114(8):742\u20139.","journal-title":"J Formos Med Assoc"},{"key":"2179_CR27","doi-asserted-by":"publisher","first-page":"1053.e1015","DOI":"10.1016\/j.wneu.2017.07.033","volume":"106","author":"A Galacho-Harriero","year":"2017","unstructured":"Galacho-Harriero A, Delgado-L\u00f3pez PD, Ortega-Lafont MP, Mart\u00edn-Alonso J, Castilla-D\u00edez JM, S\u00e1nchez-Borge B. Nocardia farcinica brain abscess: report of 3 cases. World Neurosurgery. 2017;106:1053.e1015.","journal-title":"World Neurosurgery"},{"issue":"6","key":"2179_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QCO.0000000000000404","volume":"30","author":"J Coussement","year":"2017","unstructured":"Coussement J, Lebeaux D, Rouzaud C, Lortholary O. Nocardia infections in solid organ and hematopoietic stem cell transplant recipients. Curr Opin Infect Dis. 2017;30(6):545.","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"2179_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/practneurol-2018-002038","volume":"19","author":"KR Mahajan","year":"2019","unstructured":"Mahajan KR. Disseminated nocardiosis with cerebral and subcutaneous lesions on low-dose prednisone. Pract Neurol. 2019;19(1):62\u20133.","journal-title":"Pract Neurol"},{"key":"2179_CR30","doi-asserted-by":"crossref","unstructured":"Conville PS, Brown-Elliott BA, Smith T, Zelazny AM. The complexities of nocardia taxonomy and identification. J Clin Microbiol. 2018;56(1):01419\u201317.","DOI":"10.1128\/JCM.01419-17"},{"issue":"6","key":"2179_CR31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.7150\/ijms.32440","volume":"16","author":"T Wang","year":"2019","unstructured":"Wang T, Jia Y, Chu B, Liu H, Dong X, Zhang Y. Nocardiosis in kidney disease patients under immunosuppressive therapy: case report and literature review. Int J Med Sci. 2019;16(6):838\u201344.","journal-title":"Int J Med Sci"},{"issue":"7","key":"2179_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1346-8138.2010.01166.x","volume":"38","author":"E Akasaka","year":"2011","unstructured":"Akasaka E, Ikoma N, Mabuchi T, Tamiya S, Matuyama T, Ozawa A, Saito E, Wakabayashi T, Yamada C, Aoyama K, et al. A novel case of nocardiosis with skin lesion due to Nocardia araoensis. J Dermatol. 2011;38(7):702\u20136.","journal-title":"J Dermatol"},{"issue":"5","key":"2179_CR33","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S0190-9622(98)70479-7","volume":"38","author":"T Shimizu","year":"1998","unstructured":"Shimizu T, Furumoto H, Asagami C, Kanaya K, Mikami Y, Muto M. Disseminated subcutaneous Nocardia farcinica abscesses in a nephrotic syndrome patient. J Am Acad Dermatol. 1998;38(5):874\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"19","key":"2179_CR34","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.2169\/internalmedicine.52.0453","volume":"52","author":"R Sirijatuphat","year":"2013","unstructured":"Sirijatuphat R, Niltwat S, Tiangtam O, Tungsubutra W. Purulent pericarditis and cardiac Tamponade caused by Nocardia farcinica in a nephrotic syndrome patient. Intern Med. 2013;52(19):2231\u20135.","journal-title":"Intern Med"},{"issue":"06","key":"2179_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1055\/a-0614-2871","volume":"56","author":"M Weber","year":"2018","unstructured":"Weber M, R\u00fcddel J, Bruns T, Pletz MW, Stallmach A. Pulmonary co-infection with nocardia species and nontuberculous mycobacteria mimicking miliary tuberculosis in a patient with Crohn's disease under combined immunosuppressive therapy. Z Gastroenterol. 2018;56(06):569\u201372.","journal-title":"Z Gastroenterol"},{"key":"2179_CR36","doi-asserted-by":"crossref","unstructured":"Wu Y, Yu S, Xie Q. Nocardia infection in an immunosuppressive patient with Dermatomyositis. J Clin Rheumatol. 2020;26(1):e9.","DOI":"10.1097\/RHU.0000000000000765"},{"issue":"24","key":"2179_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007211","volume":"96","author":"N Zhu","year":"2017","unstructured":"Zhu N, Zhu Y, Wang Y, Dong S. Pulmonary and cutaneous infection caused by Nocardia farcinica in a patient with nephrotic syndrome: a case report. Medicine. 2017;96(24):e7211.","journal-title":"Medicine"},{"issue":"11","key":"2179_CR38","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1093\/ndt\/gfh412","volume":"19","author":"A Sonesson","year":"2004","unstructured":"Sonesson A, Oqvist B, Hagstam P, Bjorkman-Burtscher IM, Miorner H, Petersson AC. An immunosuppressed patient with systemic vasculitis suffering from cerebral abscesses due to Nocardia farcinica identified by 16S rRNA gene universal PCR. Nephrol Dial Transplant. 2004;19(11):2896\u2013900.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2179_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1128\/CMR.19.2.259-282.2006","volume":"19","author":"BA Brown-Elliott","year":"2006","unstructured":"Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259\u201382.","journal-title":"Clin Microbiol Rev"},{"key":"2179_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.09.015","volume":"64","author":"E Canou\u00ef","year":"2017","unstructured":"Canou\u00ef E, Blanc K, Loubinoux J, Valade S, Hamard C, Lefebvre A, Amorim S, B\u00e9b\u00e9ar C, Rodriguez-Nava V, Lebeaux D. The value of molecular techniques to diagnose Ureaplasma urealyticum and Nocardia farcinica Pleuropneumonia in a Patient with Diffuse large B-Cell Lymphoma. Int J Infect Dis. 2017;64:S1201971217302394.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"2179_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/etm.2014.1715","volume":"8","author":"M Yang","year":"2014","unstructured":"Yang M, Min XU, Wei W, Gao H, Zhang X, Zhao H, Jianhua HU, Dong H, Lichen XU, Lanjuan LI. Clinical findings of 40 patients with nocardiosis: A retrospective analysis in a tertiary hospital. Exp Ther Med. 2014;8(1):25\u201330.","journal-title":"Exp Ther Med"},{"issue":"1","key":"2179_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12185-008-0099-y","volume":"88","author":"M Ono","year":"2008","unstructured":"Ono M, Kobayashi Y, Shibata T, Maruyama D, Kim S-W, Watanabe T, Mikami Y, Tobinai K. Nocardiaexalbidabrain abscess in a patient with follicular lymphoma. Int J Hematol. 2008;88(1):95\u2013100.","journal-title":"Int J Hematol"},{"issue":"11","key":"2179_CR43","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2169\/internalmedicine.2177-18","volume":"58","author":"K Kato","year":"2019","unstructured":"Kato K, Noguchi S, Naito K, Ikushima I, Hanaka T, Yamasaki K, Kawanami T, Yatera K. Pulmonary Nocardiosis caused by Nocardia exalbida in a patient with lung cancer and radiation pneumonitis: a case report and literature review. Intern Med. 2019;58(11):1605\u201311.","journal-title":"Intern Med"},{"issue":"2","key":"2179_CR44","first-page":"136","volume":"41","author":"F Mazzaferri","year":"2018","unstructured":"Mazzaferri F, Cordioli M, Segato E, Adami I, Azzini AM. Nocardia infection over 5 years (2011-2015) in an Italian tertiary care hospital. New Microbiol. 2018;41(2):136\u201340.","journal-title":"New Microbiol"},{"issue":"3","key":"2179_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1513\/AnnalsATS.201611-907OC","volume":"14","author":"MH Woodworth","year":"2017","unstructured":"Woodworth MH, Saullo JL, Lantos PM, Cox GM, Stout JE. Increasing Nocardia incidence associated with bronchiectasis at a tertiary care center. Ann Am Thorac Soc. 2017;14(3):347.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"2179_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2018.12.007","volume":"94","author":"L Huang","year":"2019","unstructured":"Huang L, Chen X, Xu H, Sun L, Li C, Guo W, Xiang L, Luo G, Cui Y, Lu B. Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017. Diagn Microbiol Infect Dis. 2019;94(2):165\u201372.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"2179_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/imj.14068","volume":"49","author":"EK Paige","year":"2019","unstructured":"Paige EK, Spelman D. Nocardiosis: 7-year experience at an Australian tertiary hospital. Intern Med J. 2019;49(3):373\u20139.","journal-title":"Intern Med J"},{"issue":"3","key":"2179_CR48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/clinids\/18.3.348","volume":"18","author":"RB Uttamchandani","year":"1994","unstructured":"Uttamchandani RB, Daikos GL, Reyes RR, Fischl MA, Dickinson GM, Yamaguchi E, Kramer MR. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis. 1994;18(3):348\u201353.","journal-title":"Clin Infect Dis"},{"key":"2179_CR49","doi-asserted-by":"crossref","unstructured":"Lebeaux D, Bergeron E, Berthet J, Djadi-Prat J, Mouni\u00e9e D, Boiron P, Lortholary O, Rodriguez-Nava V. Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010-2015. Clin Microbiol Infect. 2019;25(4):489\u201395.","DOI":"10.1016\/j.cmi.2018.06.013"},{"issue":"6","key":"2179_CR50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1053\/rmed.2003.1505","volume":"97","author":"CH Hui","year":"2003","unstructured":"Hui CH, Au V, Rowland K. Pulmonary nocardiosis re-visited: experience of 35 patients at diagnosis. Respir Med. 2003;97(6):709\u201317.","journal-title":"Respir Med"},{"issue":"2","key":"2179_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/clinids\/4.2.315","volume":"4","author":"RJ Wallace Jr","year":"1982","unstructured":"Wallace RJ Jr, Septimus EJ, Williams TW Jr, Conklin RH, Satterwhite TK, Bushby MB, Hollowell DC. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis. 1982;4(2):315\u201325.","journal-title":"Rev Infect Dis"},{"issue":"12","key":"2179_CR52","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.jocn.2009.03.029","volume":"16","author":"TT Chung","year":"2009","unstructured":"Chung TT, Lin JC, Hsieh CT, Chen GJ, Ju DT. Nocardia farcinica brain abscess in an immunocompetent patient treated with antibiotics and two surgical techniques. J Clin Neurosci. 2009;16(12):1675\u20137.","journal-title":"J Clin Neurosci"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-020-02179-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T23:59:08Z","timestamp":1669766348000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02179-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2179"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02179-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"assertion":[{"value":"14 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of Central South University, the Second Xiangya Hospital approved the study and waived the need of informed written\/verbal consent for this anonymous study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"516"}}